These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 23837924

  • 1. In vitro susceptibility of Mycobacterium avium complex mycobacteria to trimethoprim and sulfonamides.
    Muhammed Ameen S, Drancourt M.
    Int J Antimicrob Agents; 2013 Sep; 42(3):281-2. PubMed ID: 23837924
    [No Abstract] [Full Text] [Related]

  • 2. [The resistance of urinary tract bacteria in hospital environment over a 4-year period. A prospective study with special reference to trimethoprim, sulfonamide and a combination of them].
    Busk HE, Korner B, Hammer R.
    Ugeskr Laeger; 1985 Nov 25; 147(48):3895-7. PubMed ID: 3878615
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of dihydrofolate reductases from trimethoprim- and sulfonamide-resistant strains of Neisseria gonorrhoeae.
    Ho RI, Lai PH, Corman L, Ho J, Morse SA.
    Sex Transm Dis; 1978 Nov 25; 5(2):43-50. PubMed ID: 10328030
    [Abstract] [Full Text] [Related]

  • 4. Trimethoprim resistance and single-agent use.
    Maskell R, Pead L.
    Lancet; 1989 Sep 02; 2(8662):557-8. PubMed ID: 2570249
    [No Abstract] [Full Text] [Related]

  • 5. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid.
    Keys TF.
    Mayo Clin Proc; 1977 Nov 02; 52(11):680-2. PubMed ID: 926843
    [Abstract] [Full Text] [Related]

  • 6. Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.
    Suling WJ, Reynolds RC, Barrow EW, Wilson LN, Piper JR, Barrow WW.
    J Antimicrob Chemother; 1998 Dec 02; 42(6):811-5. PubMed ID: 10052907
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.
    Molina-Torres CA, Ocampo-Candiani J, Rendón A, Pucci MJ, Vera-Cabrera L.
    Antimicrob Agents Chemother; 2010 May 02; 54(5):2188-90. PubMed ID: 20231398
    [Abstract] [Full Text] [Related]

  • 8. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Jul 02; 66(7):489-92. PubMed ID: 1890791
    [Abstract] [Full Text] [Related]

  • 9. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N, Kawahara S, Tada A, Takigawa N, Shibayama T, Soda R, Takahashi K.
    Kekkaku; 2006 Apr 02; 81(4):329-35. PubMed ID: 16715941
    [Abstract] [Full Text] [Related]

  • 10. [A susceptibility study of Mycobacterium avium-intracellulare strains using the broth macrodilution method].
    Mederos Cuervo LM, Ferrá Salazar C, Jimenez Misas CA, Valdivia Alvarez JA.
    Rev Cubana Med Trop; 1995 Apr 02; 47(1):54-8. PubMed ID: 9805069
    [Abstract] [Full Text] [Related]

  • 11. [Influence of composition of the culture media on the in vitro determination of the bacterial sensitivity to sulfonamides, trimethoprim and cotrimoxazole].
    Pessione E, Gaffodio AM, Martinetto P, Giunta C, Angeretti A.
    Boll Ist Sieroter Milan; 1979 Jul 31; 58(3):234-41. PubMed ID: 518756
    [Abstract] [Full Text] [Related]

  • 12. [Results from "in vitro" resistance determinations in 9606 pathogenic microbes against the new anti-bacterial combination sulfametrol-trimethoprim].
    Kofler K, Marek A, Robber K, Semenitz E.
    Wien Med Wochenschr Suppl; 1978 Jul 31; 47():1-7. PubMed ID: 274018
    [No Abstract] [Full Text] [Related]

  • 13. Clinical mycobacteriology. Drug susceptibility testing.
    Heifets LB.
    Clin Lab Med; 1996 Sep 31; 16(3):641-56. PubMed ID: 8866184
    [Abstract] [Full Text] [Related]

  • 14. Use of the "RAM" susceptibility testing method for rapid detection of clarithromycin resistance in the Mycobacterium avium complex.
    Flauta V, Osterhout G, Ellis B, Grayson M, Sasser M, Cohen S, Sander M, Dionne K, Carroll K, Parrish N.
    Diagn Microbiol Infect Dis; 2010 May 31; 67(1):47-51. PubMed ID: 20226616
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of antimicrobial agents against mycobacteria.
    Casal M, Rodríguez F, Gutierrez J, Ruíz P, Villalba R.
    Drugs Exp Clin Res; 1988 May 31; 14(12):741-5. PubMed ID: 3150951
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.
    Inagaki T, Yagi T, Ichikawa K, Nakagawa T, Moriyama M, Uchiya K, Nikai T, Ogawa K.
    J Antimicrob Chemother; 2011 Apr 31; 66(4):722-9. PubMed ID: 21393190
    [Abstract] [Full Text] [Related]

  • 17. Errors associated with determining the susceptibilities of staphylococci to trimethoprim by the Vitek GPS-AK card.
    Carmichael IC, Godfrey V, Nicholson G.
    J Antimicrob Chemother; 1999 Aug 31; 44(2):293-4. PubMed ID: 10473241
    [No Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and sulfonamides in France.
    Ameen SM, Drancourt M.
    Antimicrob Agents Chemother; 2013 Dec 31; 57(12):6370-1. PubMed ID: 24060877
    [Abstract] [Full Text] [Related]

  • 19. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
    Hombach M, Somoskövi A, Hömke R, Ritter C, Böttger EC.
    Int J Med Microbiol; 2013 Jul 31; 303(5):270-6. PubMed ID: 23689069
    [Abstract] [Full Text] [Related]

  • 20. Resistance of urinary tract isolates of Escherichia coli to cotrimoxazole, sulphonamide, trimethoprim and ampicillin: an 11-year survey.
    Peddie BA, Bailey RR, Wells JE.
    N Z Med J; 1987 Jun 10; 100(825):341-2. PubMed ID: 3330584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.